Telsey Advisory Group Raises Bath & Body Works (NYSE:BBWI) Price Target to $23.00

Bath & Body Works (NYSE:BBWI) had its price target hoisted by equities research analysts at Telsey Advisory Group from $17.00 to $23.00 in a research note issued to investors on Friday, MarketBeat Ratings reports. The brokerage presently has a “market perform” rating on the stock. Telsey Advisory Group’s target price suggests a potential upside of 1.17% from the stock’s previous close.

BBWI has been the subject of several other research reports. Citigroup lowered Bath & Body Works from a “buy” rating to a “neutral” rating and upped their price objective for the company from $21.00 to $25.00 in a report on Tuesday, February 17th. Deutsche Bank Aktiengesellschaft started coverage on shares of Bath & Body Works in a research report on Thursday, January 8th. They issued a “hold” rating and a $21.00 price target on the stock. Barclays raised their price objective on shares of Bath & Body Works from $18.00 to $20.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 6th. Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, November 12th. Finally, UBS Group increased their target price on shares of Bath & Body Works from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, February 23rd. Three equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $23.71.

Bath & Body Works Price Performance

NYSE BBWI opened at $22.73 on Friday. Bath & Body Works has a 12 month low of $14.27 and a 12 month high of $37.29. The firm has a market capitalization of $4.65 billion, a PE ratio of 7.00, a P/E/G ratio of 1.00 and a beta of 1.54. The company’s 50 day simple moving average is $22.13 and its 200 day simple moving average is $23.72.

Institutional Investors Weigh In On Bath & Body Works

A number of large investors have recently made changes to their positions in the company. Retirement Systems of Alabama lifted its position in Bath & Body Works by 40.6% during the 3rd quarter. Retirement Systems of Alabama now owns 772,324 shares of the company’s stock worth $19,895,000 after acquiring an additional 223,089 shares during the last quarter. Summit Investment Advisors Inc. bought a new position in shares of Bath & Body Works in the first quarter worth about $1,292,000. Allianz Asset Management GmbH lifted its position in shares of Bath & Body Works by 58.8% during the 3rd quarter. Allianz Asset Management GmbH now owns 263,628 shares of the company’s stock worth $6,791,000 after purchasing an additional 97,640 shares during the last quarter. Diamond Hill Capital Management Inc. boosted its stake in Bath & Body Works by 29.9% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 369,452 shares of the company’s stock valued at $9,517,000 after purchasing an additional 85,000 shares during the period. Finally, Intech Investment Management LLC boosted its stake in Bath & Body Works by 53.5% during the 2nd quarter. Intech Investment Management LLC now owns 58,460 shares of the company’s stock valued at $1,751,000 after purchasing an additional 20,381 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

Trending Headlines about Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Telsey Advisory Group raised its price target on BBWI from $17 to $23 and kept a “market perform” rating, signaling modest analyst confidence in the company’s near-term outlook (small upside vs. current price). This can provide some support to the stock if other news is neutral. Telsey price target note
• Positive Sentiment: Bath & Body Works launched a limited-time PEEPS® fragrance and gifting collection — a seasonal product tie-in that can help drive traffic and gift-season sales if consumer demand is solid. Product collaborations are usually modest near-term positives rather than transformational. PEEPS collaboration
• Neutral Sentiment: Zacks published a preview of Wall Street projections for Bath & Body Works’ fiscal Q4 results and key metrics. Analysts’ consensus expectations for revenue, comp sales and margins will be important when BBWI reports; the preview itself doesn’t move the stock but sets the bar for the upcoming earnings reaction. Zacks Q4 preview
• Negative Sentiment: Multiple law firms (Rosen, Faruqi & Faruqi, Pomerantz, Bernstein Liebhard, The Gross Law Firm and others) have issued shareholder alerts about a securities class action covering purchases between June 4, 2024 and November 19, 2025 and are urging investors to file by mid-March deadlines (March 13–16, 2026). Heightened litigation activity increases legal and settlement risk and can weigh on the stock, especially while deadlines and potential lead-plaintiff developments are pending. See representative notices: Rosen notice Faruqi notice Gross Law Firm notice

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.